Results 91 to 100 of about 13,126,675 (165)

Use of liposomal amphotericin B in the treatment of disseminated coccidioidomycosis

, 2003
Disseminated fungal infection is an important cause of morbidity and mortality, especially in immunocompromised hosts. Amphotericin B is an important part of the therapy and treatment of invasive and life-threatening mycoses.
Dominguez, Delfina C., Sotelo, Elsa, Antony, Suresh   +2 more
core  

Safety and efficacy of liposomal amphotericin B for the empirical therapy of invasive fungal infections in immunocompromised patients

Infection and Drug Resistance, 2012
Marisa H Miceli1, Pranatharthi Chandrasekar21Oakwood Hospital and Medical Center, Dearborn, 2Division of Infectious Diseases, Wayne State University School of Medicine, Detroit, MI, USAAbstract: Liposomal amphotericin B is a "true&quot ...
Miceli MH, Chandrasekar P
doaj  

Combination therapy with liposomal amphotericin b (ambisome), n-methylglucamine antimoniate (glucantime), and pentamidine isethionate in a refractory visceral leishmaniasis case

Revista da Sociedade Brasileira de Medicina Tropical
Visceral leishmaniasis is a systemic disease that is potentially severe and endemic in Brazil. It clinically manifests as fever, weight loss, swelling, hepatosplenomegaly, paleness, and edema.
Maria Antonia Ferreira Gomes, Lana Lira Cantidio de Medeiros, Fernanda Paula Dantas Lobo, Nathália Rayane Silva Wanderley, Ana Paula Rodrigues Matos, Tácito do Nascimento Jácome, Maria Goretti Lins Monteiro, Kleber Giovanni Luz   +7 more
doaj   +1 more source

Reworking the treatment of Indian Post kala-azar dermal leishmaniasis: A two-step therapy

Journal of Vector Borne Diseases
In the current scenario, treatment of Post kala-azar dermal leishmaniasis (PKDL) is intravenous liposomal amphotericin B or oral miltefosine. Over the years, there has been a gradual decline in the efficacy of miltefosine and a rise in permanent loss of ...
Sushruta Kathuria, Yugansh Gautam, Niti Khunger, Shruti Sharma, Ruchi Singh   +4 more
doaj   +1 more source

Increase in Hb levels (A) and body weight (B) from baseline after treatment with lipid and liposomal formulations of amphotericin B (mITT population).

, 2014
Increase in Hb levels (A) and body weight (B) from baseline after treatment with lipid and liposomal formulations of amphotericin B (mITT population).
Tara Kant Jha (631050), Shyam Sundar (58354), Chandra Shekhar Lal (631051), Deepak Verma (631052), Neena Verma (505159), Chandreshwar Prasad Thakur (631049), Pradeep Das (230639), Vidya Nand Ravi Das (567509), Shahnawaz Alam (631053), Krishna Pandey (567511)   +9 more
core   +1 more source

ENDEMIC MYCOSES PROGRAM IN THE BRAZILIAN UNIFIED HEALTH SYSTEM (SUS): CASE CHARACTERIZATION AND PHARMACOECONOMIC IMPACT IN A HIGH-COMPLEXITY UNIVERSITY HOSPITAL

Brazilian Journal of Infectious Diseases
Introduction/Objectives: The Ministry of Health Endemic Mycoses Program is essential in SUS, ensuring access to high-cost antifungals for patients with systemic fungal infections, according to RENAME and Clinical Protocols and Therapeutic Guidelines ...
Andressa Barros, Gilian Batista Balbueno Guerreiro, Maitê Roxo dos Santos, Lucia Collares Meirelles   +3 more
doaj   +1 more source

Recidivans cutaneous leishmaniasis unresponsive to liposomal amphotericin B (AmBisone®)

, 2000
A 60-year-old woman with thick crusted erythematous plaques on her glabella, apex nasi and left infraorbital region was diagnosed as recidivans cutaneous leishmaniasis. The lesions were resistant to antimonial drugs.
Ayhan S., Türel A., Kandiloglu A.R., Gündüz K., Afsar S., Ok U.Z., Filiz E.E., Afsar, Sule, Türel, AYLİN, AYHAN, SEMİN, Filiz, Elif Ebru, OK, ÜLGEN ZEKİ, GÜNDÜZ, KAMER, KANDİLOĞLU, ALİ RIZA   +13 more
core   +1 more source

Case Report: Continuous antegrade liposomal amphotericin B irrigation as an adjunct to endoscopic management of a refractory renal fungal bezoar

Frontiers in Medicine
BackgroundObstructing renal fungal bezoars are rare but challenging complications of upper urinary tract candidiasis. Systemic antifungal therapy alone is often inadequate because of the high fungal burden and associated urinary obstruction.
Dania Ghaziri, Alaa Balaghi, Ghassan Al Awar, Jad Hamawi, Maher Abdessater   +4 more
doaj   +1 more source

Visceral Leishmaniasis (VL) Clinical Presentation, Laboratory Findings, Treatment Options and Outcome

Iranian Journal of Parasitology
Background: Black disease, also known as visceral leishmaniasis (VL), is a parasitic illness caused by various Leishmania species. The risk of morbidity and mortality increases with delayed diagnosis and treatment.
Mahmoud Khodabandeh, Elham Moradian, Maedeh Sarvari, Mahsa Soti Khiabani   +3 more
doaj  

Liposomal amphotericin B-the past. [PDF]

J Antimicrob Chemother, 2022
Brüggemann RJ, Jensen GM, Lass-Flörl C.   +2 more
europepmc   +1 more source